Journal
ENDOCRINE-RELATED CANCER
Volume 16, Issue 4, Pages 1065-1072Publisher
BIOSCIENTIFICA LTD
DOI: 10.1677/ERC-09-0150
Keywords
-
Categories
Funding
- Medical Research Council [G0601811] Funding Source: researchfish
- MRC [G0601811] Funding Source: UKRI
- Medical Research Council [G0601811] Funding Source: Medline
Ask authors/readers for more resources
There is mounting evidence that the serum concentration of TSH is an independent predictor for the diagnosis of thyroid malignancy in patients with nodular thyroid disease. Furthermore, preoperative serum TSH concentrations are higher in patients with more aggressive tumours, suggesting a potential role for TSH in the progression of differentiated thyroid cancer Based on these observations, patients with higher serum TSH concentrations and borderline cytological results may require more aggressive investigation and treatment when compared with those with lower baseline TSH levels. The mechanisms underlying the finding of higher serum TSH in patients with thyroid cancer remain unexplained. In this issue of Endocrine-Related Cancer, Fiore et al have analysed the relationship between serum TSH and diagnosis of papillary thyroid cancer in 10 178 patients with nodular thyroid disease who were investigated by fine-needle aspiration biopsy. They found significantly higher TSH concentrations in patients who were subsequently diagnosed with thyroid cancer compared with those with benign disease. In addition, they found that the development of autonomous thyroid function (TSH<0 4 mu U/ml) was associated with a reduction in the risk of papillary thyroid carcinoma In this commentary, the evidence regarding the association between serum TSH and thyroid cancer is discussed placing these new findings into context. Endocrine-Related Cancer (2009) 16 1065-1072
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available